Morris Jeffrey Allen

Morris Jeffrey Allen is listed in filings as 10% Owner at Provectus Biopharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Aug 14, 2024, including 1 public disclosure. Recent filings connect the profile to Provectus Biopharmaceuticals, Inc. (PVCT). The current snapshot covers public activity from Aug 14, 2024. Reported amounts are shown as $756.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.